SCHEMBL4883259

SCHEMBL4883259

CS(=O)(=O)c1cc(C(N)=O)ccc1C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
LMNA P02545 2/20 0.47
TDP1 Q9NUW8 3/20 0.47
KMT2A Q03164 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
MAPT P10636 4/20 0.45
RAB9A P51151 3/20 0.45
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HPGD P15428 2/20 0.45
PARP10 Q53GL7 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
PRKCZ Q05513 1/20 0.44
PARP1 P09874 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4887050 0.83 MMP2 (0.48) ALDH1A1LMNAHPGDL3MBTL1CYP3A4
SCHEMBL20083681 0.81 ALDH1A1 (0.61) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL4886502 0.79 CYP3A4 (0.47) ALDH1A1MAPTHPGDCYP3A4TSHR
SCHEMBL24874100 0.76 TDP1 (0.51) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL16990464 0.76 SLC9A1 (0.44) SMN1; SMN2MAPK1PARP1
SCHEMBL26376259 0.75 MAPT (0.52) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL4852019 0.75 KMT2A (0.76) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL8761237 0.74 TDP1 (0.69) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL23871905 0.73 ALDH1A1 (0.54) ALDH1A1LMNATDP1KMT2ASLC6A2
SCHEMBL2580214 0.72 TDP1 (0.66) ALDH1A1LMNATDP1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 ALDH1A1 3589/4885LMNA 3896/4885TDP1 3631/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 ALDH1A1 3589/4885LMNA 3896/4885TDP1 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.